Journal of Viral Hepatitis

Article	Citations
International disease burden of acute viral hepatitis among adolescents and young adults: An observational study	36
Issue Information	30
Issue Information	28
	28
Baseline Alpha‐Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study	25
Issue Information	24
Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab	23
240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C	22
Clinical Observational Study on HBV Reactivation After Direct‐Acting Antiviral Therapy in HCV /	22
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B	20
The role of serum sphingolipids as potential biomarkers of non‐response to direct acting antiviral therapy in chronic hepatitis C virus infection	20
Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues	19
A cross‐sectional study of hepatitis C prevalence and correlates among persons who inject drugs in rural and non‐rural communities	19
Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review	19
Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine	17
Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up (RELINK‐C strategy) and the impact of COVID‐19	17
Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination	17
Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England	17
	16
Issue Information	16
Trends and Socio‐Demographic Patterns of Hepatitis B Virus Hospitalisations in Poland: A 12‐Year Nationwide Analysis	15
Improvement of chronic HCV infection‐related depression, anxiety, and neurocognitive performance in persons achieving SVR‐12: A real‐world cohort study	15
Issue Information	15
Characterisation of People Living With Chronic Hepatitis B Virus Infection in England and Stratification by HBsAg Levels: A Cross‐Sectional Study	15
Infectivity of Hepatitis B Virus Surface Antigen‐Positive Plasma With Undetectable HBV‐DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood Donors?	15

TRPM2 regulates autophagy to participate in hepatitis B virus replication	15
Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study	14
A Network Map of Intracellular Alpha‐Fetoprotein Signalling in Hepatocellular Carcinoma	14
Integration and the risk of liver cancer—Is there a real risk?	14
Sex‐related difference analyses of efficacy and safety in clinical trials of direct‐acting antivirals to treat chronic HCV genotype 1 and 3 infections	14
Evaluation of Blood Droplet Volumes on the Cobas Plasma Separation Card for HCV RNA Testing in Resource‐Limited Settings	13
An updated assessment of hepatitis delta prevalence among adults in Canada: A meta‐analysis	13
Contribution of alcohol use in HIV/hepatitis C virus co‐infection to all‐cause and cause‐specific mortality: A collaboration of cohort studies	13
Elevation of S2‐bound α1‐acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma	13
Long‐Term Follow‐Up of Neuropsychiatric Symptoms After Sustained Virological Response to Interferon‐Free and Interferon‐Based Hepatitis C Virus Treatment	13
Reversibility of acute‐on‐chronic liver failure syndrome in hepatitis B virus‐infected patients with and without prior decompensation	13
Strategies to increase primary care provider capacity for hepatitis C care: The California ECHO‐PLUS study	12
Adenovirus vector encoding TPPII ignites HBV‐specific CTL response by activating autophagy in CD8+ T cell	12
Safe co‐administration of direct‐acting antivirals and direct oral anticoagulants among patients with hepatitis C virus infection: An international multicenter retrospective cohort study	12
Issue Information	12
Prevalence of hepatitis C in sexual assault survivors presenting to a SANE clinic: A descriptive analysis	12
Issue Information	11
A declaration from people living with hepatitis B: A call for a whole person approach	11
Epidemiology and Outcomes of Hepatitis E Virus‐Associated Hospitalisations in the United States With a Focus on Pregnancy: A Nationwide Population Study, 1998–2020	11
Serum HBV RNA is associated with liver fibrosis regression in HBeAg‐positive chronic hepatitis B patients treated with nucleos(t)ide analogues	11
Challenges of hepatitis B treatment in rural Sub‐Saharan Africa: Treatment initiation and outcomes from a public hospital‐based clinic in Kono, Sierra Leone	11
Systematic Screening for Hepatitis B, C, and HIV and Linkage to Care in Patients With Mental Health Disorders Admitted to the Emergency Department	11
The changing epidemiology of delta hepatitis in Türkiye over three decades: A systematic review	11
	11
Clinical and histological features of patients with chronic hepatitis B virus infection in the grey zone	10
Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta‐analysis	10
Sustainable and equivalent improvements in symptoms and functional well‐being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection:	10
Hepatitis E prevalence and infection in solid‐organ transplant recipients in the United States	10
HCV hotline facilitates Hepatitis C elimination during the COVID‐19 pandemic	10
The role of treatment of hepatitis C with direct‐acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta‐analysis	10
Network‐basedstrategies to combatHCV: Examining social and spatial drivers of transmission amongPWIDin New Delhi	10
	10
Universal HCV Screening in Hospitalised Patients in France: It Could Be a Good Option! The DEVICHO	9
Epidemiological Burden of Hepatitis Delta Virus in the United States	9
Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver‐related complications in patients with chronic hepatitis C receiving direct‐acting antiviral agents	9
Measuring stigma associated with hepatitis B virus infection in Sierra Leone: Validation of an abridged Berger HIV stigma scale	9
Baseline and on‐treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antivirals	9
Risk of drug‐induced liver injury in chronic hepatitis B and tuberculosis co‐infection: A systematic review and meta‐analysis	8
Does hepatitis delta virus have a preference for hepatitis B virus genotype? A systematic review of the literature	8
Hepatitis D virus infection: Progress on the path toward disease control and cure	8
Frequency, Severity and Impact of Pegylated Interferon Alpha–Associated Flares in Hepatitis D Infection	8
Prognostic value of genotyping in hepatocellular carcinoma: A systematic review	8
Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™	8
Viral hepatitis in pregnancy	8
	8
Dynamic personalized prediction of the individual liver‐related risk after sustained viral response in HCV patients	8
Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After Hepatitis C Cure (ANRS CO22 Hepather)	8
Hepatitis B e antigen and e antibody in a multi‐ethnic cohort of adult chronic hepatitis B virus patients followed at a single liver unit for a period of 20 years	8
Duration of Nucleos(t)ide Analogue Treatments in Patients With Chronic Hepatitis B Virus Infection in the United States	8
Cover image	8

The altered HLA‐DQ expression in peripheral blood T cells of chronic hepatitis B patients characterizes the function of T cells	8
Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis	8
The Efficacy and Sustainability of an Implementation Intervention ( FOCUS Program) on Linkage to Hepatitis C Care Time at a Community Health Center i	8
Universal versus targeted screening for HCV infection in pregnancy in a diverse, multi‐ethnic population: Universal screening is more comprehensive	8
Associations Between Prior and Current Unhealthy Alcohol Use and Liver Morbidity Risk and Mortality Among Veterans With a History of Hepatitis C Who Have Achieved Sustained Virological Response	7
Performance Evaluation of the Elecsys HCV Duo Immunoassay in the Public Healthcare Setting in Cape Town, South Africa	7
MELD score < 18 rule out 28‐day ACLF development among inpatients with hepatitis B‐related previous compensated liver disease	7
CHB patients with rtA181T‐mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes	7
The immune landscape in hepatitis delta virus infection—Still an open field	7
Hepatitis Delta Coinfection Rates and All‐Cause Mortality Among Hepatitis B‐Infected Veterans in the USA	7
Knowledge and Perceptions of Hepatitis B in Immigrant Populations: A Systematic Review and Thematic Synthesis of Qualitative Research	7
	7
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon‐alfa	7
Hepatitis B Vaccination Uptake and Associated Factors in the United States Before Implementing Universal Vaccination: A Nationally‐Representative Study	7
Performance of HCV core antigen and PCR testing in a predominantly genotype 3 population	7
Preferences and feasibility of long‐acting technologies for treatment of hepatitis C virus in low‐ and middle‐income countries: A survey of providers and policymakers	7
Mortality and morbidity related to hepatitis C virus infection in hospitalized adults—A propensity score matched analysis	7
	7
A Qualitative Systematic Review of Barriers and Facilitators to Hepatitis B and C Programmes in Prisons	7
	7
VirA+EmiC project: Evaluating real‐world effectiveness and sustainability of integrated routine opportunistic hepatitis B and C testing in a large urban emergency department	7
A novel test and treat program for hepatitis C virus infection utilizing HCV core antigen testing, among police and general population, Islamabad, Pakistan, 2022	6
Early clinical efficacy of pegylated interferon treatment in patients with different phases of chronic HBV infection: A real‐world analysis	6
Severe acute hepatitis of unknown origin in children: Is it still a mystery? What role does adenovirus play?	6
Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus‐Related Cirrhosis	6
Screening rates for hepatitis B and C among low‐income US veterans: Data from the National Veteran Homeless and Other Poverty Experiences Study	6
Role of hepatitis B surface antibody in seroreversion of hepatitis B surface antigen in patients achieving hepatitis B surface antigen loss with pegylated interferon‐based therapy	6
Issue Information	6
Reply to ‘Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial’	6
Substance use and CD4/CD8 ratio in HIV/HCV co‐infected people receiving direct‐acting antiviral treatment (ANRS CO13 HEPAVIH)	6
Hepatocytes and Hepatic Stellate Cells Carry Different Levels of DNA Damage due to Their Sensitivity to Oxidative Stress in Chronic Hepatitis B	6
	6
Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct‐acting antivirals	6
Phase 1 study of safety and tolerability of an oral contraceptive containing low‐dose ethinyl oestradiol combined with glecaprevir/pibrentasvir treatment in healthy premenopausal women	6
Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis	6
Impact of COVID‐19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs	6
MiRNome Profiling of Circulating Extracellular Vesicles in Patients With Chronic Hepatitis D Undergoing Pegylated Interferon Alpha Treatment	6
Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C Virologic Cure	6
Issue Information	6
Risk factors for hepatitis C virus infection at a large urban emergency department	6
Balancing Efficiency and Accuracy in Hepatitis C Rapid Antibody Testing: Insights From a Cluster Randomised Crossover Trial	6
Barriers and enablers to people‐centred viral hepatitis care in Vietnam and the Philippines: Results of a patient journey mapping study	6
Post‐vaccination serologic testing of infants born to hepatitis B surface antigen‐positive mothers is more cost‐effective in Zhejiang Province, China: A Markov chain analysis	5
Screening, Prevalence and Management of Chronic Viral Hepatitis C in Mental Health Setting: Towards the Eradication of A Forgotten Reservoir	5
Sequence characterization of extracellular HBV RNA in patient plasma	5
Towards hepatitis C elimination in France: Scanvir, an effective model to test and treat drug users on dedicated days	5
HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre‐ and posttreatment: a multicentre observational cohort study	5
Trends in Use of Direct‐Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016–2024	5
Outcomes of a 1‐Year Pilot Study Implementing Universal Hepatitis Delta Virus Testing Among Veterans With Chronic Hepatitis B	5
Prevalence of hepatitis C among pregnant women in an Appalachian population	5
Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy	5
Prevalence of hepatitis B virus (HBV) and latent tuberculosis co‐infection and risk of drug‐induced liver injury across two large HBV cohorts in the United	5
Issue Information	5
Cigarette Smoking Is Associated With Lower Chance of Hepatitis B Surface Antigen Seroclearance and Altered Host Immunity	5
	5
Hepatitis C prevalence and elimination planning in Pakistan, a bottom‐up approach accounting for provincial variation	5
Impact of treatment with direct‐acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co‐infected individuals	5
Lower Serum Albumin Level: A Prospective Risk Predictor of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection	5
	5
Genetic substructure and host‐specific natural selection trend across vaccine‐candidate ORF‐2 capsid protein of hepatitis‐E virus	5
Depletion of circ_0088046 suppressed cell growth and motility of hepatocellular carcinoma via circ_0088046‐miR‐1299‐RTKN2 ceRNA pathway	5
A morphometric analysis of hepatitis B subviral particles shows no correlation of filament proportion and length with clinical stage and genotype	5
The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection	5
Outcomes of Assisted Reproductive Technology in Women With Hepatitis B Infection	5
Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus Infection With Interferon or Direct Antiviral Therapy	5
Prevalence and Factors Associated With Hepatitis B Virus Infection in Tigray Region, Northern Ethiopia	5
Substance use and CD4/CD8 ratio in HIV/HCV co‐infected people receiving direct‐acting antiviral treatment (ANRS CO13 HEPAVIH): Authors' reply	5
	5
A Programme of Hepatitis C Surveillance With Active Linkage to Care (HEAL) for Inpatients in Two Tertiary Hospitals in Jiangsu, China	5
Closing the hepatitis C treatment gap: United States strategies to improve retention in care	5
	5
Persistence of antibodies 5 years after hepatitis B vaccination in preterm birth children: A retrospective cohort study using real‐world data	5
Cover Image	5
Impact of Universal Screening for HDV in HBV‐ Infected Patients on Chronic	4
Chronic viral hepatitis C micro‐elimination program using telemedicine in Guigang city	4
Shear wave elastography: How well does it perform in chronic hepatitis D virus infection?	4
Issue Information	4
	4
	4
Determining the frequency and characteristics of Hepatitis C reinfections in North East England	4

Demographic and Clinical Characteristics of Patients With Hepatitis C and Hepatitis B Co‐Infection, Georgia, 2017–2023	4
Efficacy and safety of pan‐genotypic sofosbuvir and velpatasvir in patients with hepatitis C and HIV coinfection on dolutegravir‐based antiretroviral therapy	4
Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment	4
Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B‐coinfected adults in care in the United States	4
Issue Information	4
Testing to sustain hepatitis C elimination targets in people who inject drugs: A network‐based model	4
	4
	4
A randomized phase 1b trial of the active site polymerase inhibitor nucleotide ATI‐2173 in patients with chronic hepatitis B virus infection	4
Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial	4
Bulevirtide Monotherapy or in Combination for Chronic Hepatitis Delta: 2025 Update	4
Protective Role of Coffee in Chronic Liver Disease: A Focus on Processing	4
Hepatitis C active viremia over time in an ED‐based testing programme: Impact, disparities and surveillance tool	4
Impact of Non‐Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha	4
Hepatitis after gene therapy, what are the possible causes?	4
Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States	4
Issue Information	4
Factors influencing compliance with Hepatitis C treatment in patients transitioning from prison to community—A summary scoping review	4
Regarding the predictive role of CXCL16 in liver inflammation in chronic hepatitis B patients	4
Reply to: ‘Abnormal liver function tests and coronavirus disease 2019: A close relationship’	4
Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID‐19 pandemic	4
Test characteristics for combining non‐invasive liver fibrosis staging modalities in individuals with Hepatitis C virus	4
Time to Hepatitis C Care Engagement and Treatment Outcomes in Canadian Immigrants Have Markedly Improved Over Three Decades	4
	3
	3
Updated Guidelines for the Prevention and Management of Chronic Hepatitis B—World Health Organization 2024 Compared With China 2022 HBV Guidelines	3
Occult hepatitis B virus infection and current perspectives on global WHO 2030 eradication	3
MicroRNA‐206 inhibits HCV proliferation through depressing ACC1 lipid synthesis signalling pathway	3
Targeted Screening for Hepatitis B: Insights From Hong Kong and Implications for Endemic Regions	3
Chronic hepatitis C virus infections in Switzerland in 2020: Lower than expected and suggesting achievement of WHO elimination targets	3
Racial discrimination, knowledge, and health outcomes: The mediating role of hepatitis B‐related stigma among patients with chronic hepatitis B	3
Antiviral therapy response in patients with chronic hepatitis B and fatty liver: A systematic review and meta‐analysis	3
Comparison of acknowledged hepatocellular carcinoma risk scores in high‐risk hepatitis C patients with sustained virological response	3
Response to “Reply to ‘Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial’”	3
Cover Image	3
Prescriber Specialty Involvement in Medicare Patients With Chronic Hepatitis B	3
Issue Information	3
Evaluation of a pilot emergency department linkage to care program for patients previously diagnosed with Hepatitis C	3
Impact of prior HBV, HAV, and HEV infection on non‐alcoholic fatty liver disease	3
Recombinant human thrombopoietin increases platelet count in severe thrombocytopenic patients with hepatitis B‐related cirrhosis: Multicentre real‐world observational study	3
Accuracy of International Guidelines in Identifying Normal Liver Histology in Chinese Patients With HBeAg‐Positive Chronic HBV Infection	3
Bridging the Gap: How Distance to Hospitals Limits HCV Treatment Initiation in France	3
Incidence of primary hepatitis C infection among people who inject drugs during 2012–2020 in Athens, Greece	3
Expanding Hepatitis C Virus Treatment in the New Mexico State Prison System: Using the ECHO Model for Provider and Prison Peer Education	3
Epidemiology, linkage to care and natural history of women of childbearing age with chronic hepatitis B: A population‐based study	3
Issue Information	3
Hepatitis B Care and Treatment in Zanzibar, Tanzania: A Demonstration Project Following 2015 WHO Treatment Guidelines, 2017–2021	3
Hepatitis C care cascade before and during the direct‐acting antiviral eras in New South Wales, Australia: A population‐based linkage study	3
U‐Shaped Relationship Between CT‐Measured Liver‐To‐Spleen Volume Ratio and Mortality in HBV‐ACLF Patients	3
	3
Significance of serum HBV RNA in non‐cirrhotic HBeAg‐negative chronic hepatitis B patients who discontinue effective antiviral therapy	3
Evaluating the cost‐effectiveness of hepatitis B vaccination strategies in high‐impact settings for adults	3
Real‐World Evaluation of Point‐of‐Care Testing for Hepatitis C Antibodies: Navigating Hepatitis C Elimination Effort	3
Non‐Specialist Physicians Successfully Treat Hepatitis C Infection With Simplified Care Pathway in France	3
A Health Systems Strengthening Approach to Address the High Burden of Hepatitis C in Pakistan	3
Changes in the prevalence of hepatitis B and C viral infections in Sindh province, Pakistan: Findings from two sero‐surveys in 2007 and 2019	3
Association of MASLD Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk Factors	3
Issue Information	3
Community Pop‐Up Clinic: Cascade of Care and HCV Treatment of Vancouver's Inner‐City PWID Populations	3
Immunotherapy Using HBV Vaccine Pulsed DCs and Induced T‐Cells Combined Antiviral Drugs in Treatment Naive CHB Patients‐A Multi‐Centre Phase II Study	3
Thyroid dysfunction incidence and risk factors in Chinese chronic hepatitis B patients treated with pegylated interferon alpha: A long‐term follow‐up study	3
Human Herpesvirus 6 in Acute Liver Failure: Leading Role, Supporting Actor or Innocent Bystander? A Case Series, Narrative Review and Management Algorithm Proposal	3
Chronic hepatitis B beyond clinical burden: Psychosocial effects and impact on quality of life	2
Prognosis of hepatitis E infection in patients with chronic liver disease: A meta‐analysis	2
Correlates of chronic hepatitis B virus infection in the general adult population of China: Systematic review and meta‐analysis	2
Comparison of HBV DNA and RNA markers in Alaska Native people who did and did not clear hepatitis B surface antigen	2
Hepatitis C virus‐specific immune responses following direct‐acting antivirals administered during recent hepatitis C virus infection	2
Longitudinal Profiles of Cytokines and Chemokines in Self‐Limiting Hepatitis E	2
Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis	2
Predictors of engagement in screening for a hepatitis C virus (HCV) treatment trial in a rural Appalachian community	2
Geographic variation in HCV treatment penetration among people who inject drugs in Baltimore, MD	2
A novel non‐invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD	2
	2
Age, ethnicity and proximity to clinic determine retention in care of chronic hepatitis B patients	2
Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C Testing and Treatment With Pharmacy Clients: A Representative Cross‐Sectional Survey	2
	2
Prognosis of Acute HEV Infection in Patients With Liver Cirrhosis: A Retrospective Study of 628 Chinese Patients	2
Use of hepatitis B virus DNA and liver stiffness in predicting clinical events in patients with chronic hepatitis B	2
Single‐Cell Transcriptome Identifies a Proinflammatory B‐Cell Subset in Hepatitis B Virus Associated Acute‐on‐Chronic Liver Failure	2
Poor linkage to care may compromise the Brazilian plan for hepatitis C elimination	2
	2
More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study	2
Safety, pharmacokinetics and antiviral activity of ABI‐H2158, a hepatitis B virus core inhibitor: A randomized, placebo‐controlled phase 1 study	2
Early Read‐Time Performance of the OraQuick HCV Rapid Antibody Assay for the Exclusion of HCV Viremia	2
Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs	2
Global elimination of HBV: Is it really achievable?	2
Evaluation of Knowledge, Attitudes and Practices for Hepatitis B Virus Infection Among Primary Healthcare Physicians in Georgia	2
Automated electronic health registry‐based hepatitis B screening	2
Dysregulated metabolites and lipids in serum of patients with acute hepatitis E: A longitudinal study	2
Artificial liver support systems for hepatitis B virus‐associated acute‐on‐chronic liver failure: A meta‐analysis of the clinical literature	2
Global prevalence of occult hepatitis B: A systematic review and meta‐analysis	2
Misuse of the Lower Limit of Detection in HBV DNA Testing and Anti‐HBe Positive Status Will Significantly Impact the Diagnosis of Occult HBV Infection	2
Research progress on detection methods for hepatitis B virus covalently closed circular DNA	2
Abnormal liver function tests and coronavirus disease 2019: A close relationship	2
	2